UPDATE: This study has been completed with the full analysis of all 54 patients. Click here for full results. Earlier this month, during the most…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
Yesterday, at the annual meeting of the American Society of Gene and Cell Therapy in Chicago, researchers from Memorial Sloan Kettering Cancer Center released a…
Mesothelioma scientists and medical professionals convene at several conferences every year (one of which is our Symposium, the scientific portion of which will take place…
A new article reviewing progress and advances that occurred in 2017 in the management of pleural mesothelioma was just published in the May 2018 issue…
In 2004, over 14 years ago (!), the FDA approved the first ever (and the last so far) mesothelioma treatment drug – Alimta (pemetrexed) in…
Meet Jessica. Mother, wife, daughter, mesothelioma warrior. Jessica was diagnosed with peritoneal mesothelioma in June 2015. As to be expected, her reaction was a mix…
If you missed previous installments of Christopher Graham’s story, read them now: chapter 1, chapter 2, chapter 3, chapter 4, chapter 5, chapter 6 by Christopher Graham…
by Christopher Graham People sometimes think it’s because the doctor doesn’t respect your time. Or that, they decided to come into the office late that…
by Christopher Graham I didn’t fully appreciate the impact of the chemotherapy until I came back from my treatment break. I knew the belly pain…
It was recently announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) designated nintedanib, an oral triple angiokinase inhibitor by Boehringer Ingelheim,…